| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202971A2 Pharmaceutical compositions comprising 4-quinolones |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/08/2002 | EP1202955A2 1,4-substituted 4,4-diaryl cyclohexanes |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202722A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 05/08/2002 | EP1202628A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0737197B1 Amino alkanoic esters of rapamycin |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348436A Novel ligands of nuclear receptors PPAR's |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1348332A Vaccines and gene therapy compositions and methods of making and using the same |
| 05/08/2002 | CN1084208C Medicine for treating Baisai's disease and its preparing method |
| 05/08/2002 | CN1084204C Health-care fleece flower root-pollen food |
| 05/08/2002 | CN1084203C Health-care tortoise-turtle-pollen food |
| 05/08/2002 | CN1084202C Health-care notoginseng-pollen food |
| 05/08/2002 | CN1084201C Health-care saffron-notoginseng-pollen food |
| 05/08/2002 | CN1084197C Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process |
| 05/07/2002 | US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/07/2002 | US6384203 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6384086 Administering to host effective amount of storage stable ethene for improving metabolic function |
| 05/07/2002 | US6384085 Antioxidative ingredients extracted from powdered ecklonia cava one or more times with organic solvent, fractionated one or more times in solvents, and purified by chromatography |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/07/2002 | US6384046 Treating neointimal proliferation and thickening |
| 05/07/2002 | US6383799 Culturing tremella mesenterica in submerged culture on nutrient media, then isolating biomass by alcohol precipitation |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383494 Heat shock proteins |
| 05/07/2002 | US6383493 Methods and compositions for eliciting an immune response with hsp70-peptide complexes |
| 05/07/2002 | US6383492 Treatment of infectious diseases with gp96-peptide complexes |
| 05/07/2002 | US6383491 Prevention of infectious diseases with hsp90-peptide complexes |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | CA2175842C Transesterified corn oil products |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034904A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034790A1 Variant igg3 rituxan r and therapeutic use thereof |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034761A1 Pyranoside derivatives |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/02/2002 | WO2002034719A1 Nitrogenous saturated heterocycle compounds |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034290A2 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma |
| 05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
| 05/02/2002 | WO2002034284A2 Methods of therapy for hiv infection |
| 05/02/2002 | WO2002034252A1 Drug composition comprising dipeptydyl aldehyde derivative |
| 05/02/2002 | WO2002034245A2 Use of tolterodine to treat asthma |
| 05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001094529A3 A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001090332A3 Dna repair polypeptides and methods of use |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001046394A3 Mammalian protein phosphatases |
| 05/02/2002 | WO2001045688A3 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 05/02/2002 | WO2001044264A3 Novel stromelysin inhibitors |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | WO2001035949A3 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | WO2001000237A9 Synthetic peptide immunogens and antibodies thereto |
| 05/02/2002 | US20020052530 Such as 3-(N-1-indanylamino)-indan-1-one 3-(N-1-indanylamino) indan-1-one formed by reacting amino-indane compound with bromo-indanone compound in presence of triethyleneamine |